Mentions
Extended reach
Total likes
Video views
AI synopsis
Discussions display a balanced mix of support and curiosity, exemplified by references to official updates from BJOG and concerns about risks like hypoglycemia, highlighting the relevance of the guidelines. The tone varies from informational to questioning, demonstrating both acknowledgment of the impact and room for debate on clinical decisions.
Most discussants acknowledge the importance of the guidelines, especially referencing authoritative sources like BJOG and NICE, indicating general support.
The topics generate moderate interest, with commenters highlighting updates and debates on implementation, though there is some questioning of specific risks.
Discussions include references to official guidelines and personal observations, suggesting active engagement but limited in-depth analysis.
The conversation recognizes the significance of the updates for clinical practice, with suggestions that guideline changes could influence neonatal outcomes and hospital workloads.
@drbretty ANS in UK is 100% an Obstetric colleagues decision based on https://t.co/17aXczzVzO BAPM allows risk stratification and discussion with family on how best to proceed rather than strict recommendation. Many colleagues, understandably, find this discussion challenging.
BJOG published an important antenatal corticosteroids guideline update in 2022. This RCOG Green-top Guideline was a research highlight of 2022. >> https://t.co/lWPAjkqMo3 @BJOGTweets @RCObsGyn #OBGYNtwitter https://t.co/fQJIa9sZUG
@maiab This is the age I most often see the conversation, 35-37ish weeks gestation; as you can see it does reduce risk of respiratory issues but increases hypoglycaemia so ??? is it worth it??? https://t.co/a14AyfyuYF https://t.co/RMjp6bbKqs
@BrianKingNeo This the Royal College/NICE recommendation in UK https://t.co/XNSkySEqxW https://t.co/wak6FFprUd
Important update to antenatal steroids guideline published 16/2/2022! Please retweet! https://t.co/UslIi7QgxQ
BJOG published an important antenatal corticosteroids guideline update in 2022. This RCOG Green-top Guideline was a research highlight of 2022. >> https://t.co/EJnYH9cjMz @BJOGTweets @RCObsGyn #OBGYNtwitter https://t.co/H1ArHtW075
This video explains RCOG guidelines on antenatal corticosteroids to reduce neonatal morbidity and mortality. It covers administration timing, dosage, types of corticosteroids, and their role in promoting lung maturity…
This episode explores the use of antenatal steroids in preterm labor, examining their benefits in reducing neonatal complications and the potential long-term risks for mothers and babies, including behavioral disorders…
@maiab This is the age I most often see the conversation, 35-37ish weeks gestation; as you can see it does reduce risk of respiratory issues but increases hypoglycaemia so ??? is it worth it??? https://t.co/a14AyfyuYF https://t.co/RMjp6bbKqs
Ref : https://t.co/GfZW9HbEV7
@drbretty ANS in UK is 100% an Obstetric colleagues decision based on https://t.co/17aXczzVzO BAPM allows risk stratification and discussion with family on how best to proceed rather than strict recommendation. Many colleagues, understandably, find this discussion challenging.
RT @NicUof: @BrianKingNeo This the Royal College/NICE recommendation in UK https://t.co/XNSkySEqxW https://t.co/wak6FFprUd
@BrianKingNeo This the Royal College/NICE recommendation in UK https://t.co/XNSkySEqxW https://t.co/wak6FFprUd
BJOG published an important antenatal corticosteroids guideline update in 2022. This RCOG Green-top Guideline was a research highlight of 2022. >> https://t.co/EJnYH9cjMz @BJOGTweets @RCObsGyn #OBGYNtwitter https://t.co/H1ArHtW075
BJOG published an important antenatal corticosteroids guideline update in 2022. This RCOG Green-top Guideline was a research highlight of 2022. >> https://t.co/lWPAjkqMo3 @BJOGTweets @RCObsGyn #OBGYNtwitter https://t.co/fQJIa9sZUG
Someone anonymous to me (whose whatsapp icon is a cat) sent me this. Significant shift away from ANS in later preterm? Might it keep NNUs busy?https://t.co/5nQo0GUcUD
RT @AbfabRosie: Important update to antenatal steroids guideline published 16/2/2022! Please retweet! https://t.co/UslIi7QgxQ
Important update to antenatal steroids guideline published 16/2/2022! Please retweet! https://t.co/UslIi7QgxQ